UK approves use of Redsewe to treat some new coronary pneumonia patients

Read: The Department of Health and Social Care announced recently that the antiviral drug Remdesivir will be used to support patients with new coronavirus pneumonia patients who meet certain clinical standards
, the Department of Health and Social Health announced that the antiviral drug Remdesivir will be used to support patients with new types of co-op sinfy pneumonia that meet certain clinical standardsUK will offer some patients with new coronavirus pneumonia innovative drugs that are working well in clinical trialsUK government is working with biopharmaceutical company Gilead Sciences to provide Redsewell to the NHS, a large international study, including the UK Research Centre, has shown that Redsewe can shorten the recovery time for patients with new coronavirus pneumoniaclinical trials of Redsewe are taking place in the UK and around the world, with early data showing that the drug could reduce patient recovery time by about four daysthe UK Early Access Scheme (EAMS) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) scientific advice to support NHS patients who meet specific clinical criteria for treatment in RedseweCurrently, patients who are likely to achieve the greatest benefits will be given priority access to treatment due to limited availability of drugsUK government will continue to work closely with relevant agencies, health systems and industry to enable patients in the UK to access the latest and breakthrough treatments as quickly as possibleResponsibility Editor::UK, new crown pneumonia treatment0
00